Liver disease (hepatitis, cirrhosis) decisions — 2006

The Board found no evidence of hepatitis C or skin disorder due to Agent Orange exposure during service, and the veteran's current conditions are not related to his military service.,Impotence and prostate disorder were diagnosed post-service and there is insufficient evidence linking these conditions to service.

The veteran's claims for diabetes mellitus and cirrhosis of the liver were denied as they are not shown to be related to service. The claim for increased evaluation for residuals of a low back injury was also denied, but only prior to September 26, 2003. The claim for compensable evaluation for calluses of the feet was denied and the TDIU claim was also denied.

The VA determined that the veteran's current diagnosis of hepatitis C is not related to his military service, and thus denied his claim for service connection.

The Board denied the veteran's claim for service connection for atrophied right kidney and his claim for compensation under 38 U.S.C.A. § 1151 for hepatitis C, both of which were previously denied as not well grounded.,The evidence received since the April 2000 rating decision did not raise a reasonable possibility of substantiating the claims.

The veteran's hepatitis C is found to have been incurred during service, and the claim for service connection is granted.

The Board has determined that the veteran's hepatitis C warrants a 20 percent rating, reflecting his symptoms of daily fatigue, malaise, and anorexia.

The Board has determined that the veteran contracted hepatitis C during his military service and granted service connection for this condition.

The veteran is seeking service connection for Hepatitis C, which he claims was caused by air gun vaccinations in service. The Board has requested a VA medical opinion and will remand the case to allow further development of his claim.

The Board has denied the veteran's claims for service connection for hepatitis C and infectious hepatitis/hepatitis A as there is no medical evidence of current disability.

The veteran's hepatitis C and associated liver disease were found to warrant a 30 percent rating prior to March 23, 2004. The claim for a higher rating is denied.

The veteran's claims for service connection for PTSD and hepatitis C are being remanded due to the need for additional records and investigations.

The veteran's claims for service connection were denied as there was no evidence of a current disability, and the positive PPD test did not constitute a compensable condition.

The Board has ordered additional development due to the need for medical records and a VA medical opinion regarding whether the veteran's death was caused by or accelerated by VA treatment, specifically blood transfusions at the Miami VAMC.

The VA denied the veteran's claim for service connection for hepatitis C, concluding that there is no evidence linking his current condition to any incident in service.

The Board denied service connection for hepatitis C and bipolar disorder, finding that there was no evidence of these conditions during active service or a link to service.

The Board has granted service connection for hepatitis C, finding that the veteran's current diagnosis is as likely as not related to his military service due to in-service high risk sexual activity and tattoos.

The Board has determined that the veteran's death was caused by Hepatitis C, which developed due to IV drug use related to his service-connected PTSD. As a result, the cause of death is considered service connected.

The Board denied the veteran's claims for service connection for PTSD, hepatitis C, and a disability rating in excess of 30 percent for post-operative hallux valgus.

The Board has denied the veteran's claims for service connection for a hip disability, residuals of cold injuries to the hands and lower extremities, and an increased rating for hepatitis B. The evidence does not support current diagnoses or show that these conditions are related to service.

The veteran's hepatitis C was rated at 30 percent effective from May 15, 2000. The condition is characterized by minimal liver damage with associated fatigue and gastrointestinal disturbance that necessitates therapeutic measures.